FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1964143773> ?p ?o ?g. }

• W1964143773 endingPage "640" @default.
• W1964143773 startingPage "632" @default.
• W1964143773 abstract "Objectives. The goal of the present study was to determine the efficacy of combinatorial treatment using cisplatin and tumor necrosis factor-related apoptosis including ligand (TRAIL) to promote apoptosis in granulosa cell tumor (GCT) lines, in vitro. Methods. Two human GCT lines (COV434 and KGN) were treated with cisplatin or TRAIL, alone or in combination. The cytotoxic effects of each treatment were evaluated using a methyl tetrazolium salt (MTS) assay. Initiation of TRAIL-induced apoptosis was verified by PARP- and FLIP-cleavage. Overexpression and knockdown studies were conducted to evaluate the role of p53 in TRAIL-induced cell death. Real-time PCR was used for gene expression analysis of the TRAIL receptor dr5 and the pro-apoptotic bax following treatment with cisplatin. Results. Treatment with TRAIL (100–200 ng/ml) led to a slight, but significant, loss of cell viability following an 18-h culture. This effect was enhanced following pre-treatment with cisplatin (25 μM) for 2 or 18 h. Moreover, pre-treatment with cisplatin decreased the maximal effective dose of TRAIL from 100 ng/ml to as low as 3 ng/ml in both cell lines. GCT lines overexpressing or deficient in p53 were used to determine the requirement for p53 on TRAIL-induced apoptosis. While the level of p53 expression enhanced both the death-inducing and TRAIL-sensitizing effects of cisplatin, TRAIL-induced cell death was found to occur independent of p53. Conclusions. These data suggest that the efficacy of cisplatin in GCT cells can be enhanced through combinatorial treatment with TRAIL. This result is due to both p53-dependent (cisplatin) and -independent (TRAIL) mechanisms. Combinatorial treatment of GCTs with cisplatin and TRAIL may provide an efficacious addition to cisplatin-based regimens." @default.
• W1964143773 created "2016-06-24" @default.
• W1964143773 creator A5034797093 @default.
• W1964143773 creator A5061205384 @default.
• W1964143773 creator A5085510349 @default.
• W1964143773 date "2008-03-01" @default.
• W1964143773 modified "2023-09-23" @default.
• W1964143773 title "Cisplatin-mediated sensitivity to TRAIL-induced cell death in human granulosa tumor cells" @default.
• W1964143773 cites W1484817497 @default.
• W1964143773 cites W1520292475 @default.
• W1964143773 cites W1968747163 @default.
• W1964143773 cites W1975024594 @default.
• W1964143773 cites W1980919524 @default.
• W1964143773 cites W1984709119 @default.
• W1964143773 cites W1986705787 @default.
• W1964143773 cites W1992460461 @default.
• W1964143773 cites W2000947811 @default.
• W1964143773 cites W2007681284 @default.
• W1964143773 cites W2035207372 @default.
• W1964143773 cites W2042316019 @default.
• W1964143773 cites W2045086385 @default.
• W1964143773 cites W2057392571 @default.
• W1964143773 cites W2061564388 @default.
• W1964143773 cites W2062889363 @default.
• W1964143773 cites W2069175442 @default.
• W1964143773 cites W2072188392 @default.
• W1964143773 cites W2072380594 @default.
• W1964143773 cites W2089476060 @default.
• W1964143773 cites W2092508425 @default.
• W1964143773 cites W2103379588 @default.
• W1964143773 cites W2107277218 @default.
• W1964143773 cites W2113505777 @default.
• W1964143773 cites W2122562627 @default.
• W1964143773 cites W2130988210 @default.
• W1964143773 cites W2135300227 @default.
• W1964143773 cites W2138165502 @default.
• W1964143773 cites W2142289678 @default.
• W1964143773 cites W2146882135 @default.
• W1964143773 cites W4244435500 @default.
• W1964143773 doi "https://doi.org/10.1016/j.ygyno.2007.11.034" @default.
• W1964143773 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18191995" @default.
• W1964143773 hasPublicationYear "2008" @default.
• W1964143773 type Work @default.
• W1964143773 sameAs 1964143773 @default.
• W1964143773 citedByCount "29" @default.
• W1964143773 countsByYear W19641437732012 @default.
• W1964143773 countsByYear W19641437732013 @default.
• W1964143773 countsByYear W19641437732014 @default.
• W1964143773 countsByYear W19641437732016 @default.
• W1964143773 countsByYear W19641437732018 @default.
• W1964143773 countsByYear W19641437732020 @default.
• W1964143773 countsByYear W19641437732021 @default.
• W1964143773 crossrefType "journal-article" @default.
• W1964143773 hasAuthorship W1964143773A5034797093 @default.
• W1964143773 hasAuthorship W1964143773A5061205384 @default.
• W1964143773 hasAuthorship W1964143773A5085510349 @default.
• W1964143773 hasConcept C104317684 @default.
• W1964143773 hasConcept C126322002 @default.
• W1964143773 hasConcept C154317977 @default.
• W1964143773 hasConcept C173396325 @default.
• W1964143773 hasConcept C17991360 @default.
• W1964143773 hasConcept C182979987 @default.
• W1964143773 hasConcept C185592680 @default.
• W1964143773 hasConcept C190283241 @default.
• W1964143773 hasConcept C202751555 @default.
• W1964143773 hasConcept C2776694085 @default.
• W1964143773 hasConcept C2778239845 @default.
• W1964143773 hasConcept C31573885 @default.
• W1964143773 hasConcept C502942594 @default.
• W1964143773 hasConcept C53227056 @default.
• W1964143773 hasConcept C54355233 @default.
• W1964143773 hasConcept C55493867 @default.
• W1964143773 hasConcept C66008609 @default.
• W1964143773 hasConcept C71924100 @default.
• W1964143773 hasConcept C81885089 @default.
• W1964143773 hasConcept C82381507 @default.
• W1964143773 hasConcept C86803240 @default.
• W1964143773 hasConceptScore W1964143773C104317684 @default.
• W1964143773 hasConceptScore W1964143773C126322002 @default.
• W1964143773 hasConceptScore W1964143773C154317977 @default.
• W1964143773 hasConceptScore W1964143773C173396325 @default.
• W1964143773 hasConceptScore W1964143773C17991360 @default.
• W1964143773 hasConceptScore W1964143773C182979987 @default.
• W1964143773 hasConceptScore W1964143773C185592680 @default.
• W1964143773 hasConceptScore W1964143773C190283241 @default.
• W1964143773 hasConceptScore W1964143773C202751555 @default.
• W1964143773 hasConceptScore W1964143773C2776694085 @default.
• W1964143773 hasConceptScore W1964143773C2778239845 @default.
• W1964143773 hasConceptScore W1964143773C31573885 @default.
• W1964143773 hasConceptScore W1964143773C502942594 @default.
• W1964143773 hasConceptScore W1964143773C53227056 @default.
• W1964143773 hasConceptScore W1964143773C54355233 @default.
• W1964143773 hasConceptScore W1964143773C55493867 @default.
• W1964143773 hasConceptScore W1964143773C66008609 @default.
• W1964143773 hasConceptScore W1964143773C71924100 @default.
• W1964143773 hasConceptScore W1964143773C81885089 @default.
• W1964143773 hasConceptScore W1964143773C82381507 @default.
• W1964143773 hasConceptScore W1964143773C86803240 @default.

• next